 |
|
|
 |
|
Rationale:
- High body weight affects fetal outcome, and intrauterine imprinting can affect long-term control of body weight.
|
|
Evidence:
- Strong evidence supports the association between gestational weight gains and pre-term birth, low birth weight, macrosomia
(1), large-for-gestational age infants, small-for-gestational age infants, and neonatal mortality, particularly among blacks
(2; 3; 4; 5; 6; 7).
- Weight gain in pregnancy predicts childhood weights. Odds of overweight at age 7 are increased by 3% for every 1 kg of gestational
weight gain (8).
- A meta-analysis shows that maternal obesity is associated with an increased risk of neural tube and other (9) congenital defects during pregnancy (10).
- Smoking during pregnancy increases the risk of obesity in male and female offspring (11; 12; 13; 14; 15; 16; 17; 18; 19) by 50% (adjusted OR, 1.50 [CI, 1.36 to 1.65]) (20), particularly in white women. Only black women who smoked heavily had heavier children. Smoking among Asian and Native American
women had much less effect (21).
- The risk of gestational diabetes increases with increasing BMI (22), and gestational diabetes increases birth weight and subsequent risk of obesity (23; 24). According to one report, the outcome for infants and mothers with type 1 diabetes also depends on duration of breast feeding
and infant birth size (25).
- There is a positive trend for childhood overweight with maternal glucose screening values; treatment of gestational diabetes
attenuates this relation (26).
- Prepregnancy weight, weight gain during pregnancy, chronic or gestational diabetes, and hypertension increase risk for cesarean
delivery (27; 28; 29; 30; 31). Women with gestational diabetes who gain more than 10 lb before their next pregnancy also have an increased risk of having
a cesarean section (32).
- Infants who are small for gestational age are at higher risk for diabetes, hypertension, and the metabolic syndrome (33).
- Higher maternal prepregnancy weight (34), higher gestational weight gain (29), and maternal age (29) increase the risk (odds ratio >2) for childhood weight above the 95th percentile (18; 35; 36) and for the metabolic syndrome (37; 38).
- Obesity is associated with increased risk of hypertensive disorders (39), stillbirth (40), cesarean delivery, fetal distress, and early neonatal death, particularly in nulliparous women (41; 42; 43; 44), but BMI is a weak predictor of pre-eclampsia (45).
- Children of women who were both overweight and gained a large amount of weight during gestation had a two-fold risk of attention-deficit
hyperactivity disorder symptoms (OR, 2.10 [CI, 1.19 to 3.72]) compared to those of normal-weight women (46).
|
|
Comments:
|
| FAQs |
|
|
|
George A. Bray, MD, is a speaker for Eli Lilly, Amylin Corp., and Merck & Co., received grants from Merck & Co., and Takeda Pharmaceuticals; and
has consulted for Sanofi-Aventis, Merck, and Amylin. Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|